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Abstract
Objective:  To  conﬁrm  whether  ﬁne  needle  aspiration  biopsy  (FNAB)  can  avoid  close  monitoring,
a source  of  worry  for  women  patients  with  a  suspected  ﬁbroadenoma  found  by  ultrasound,  and
requiring their  compliance.
Patients  and  methods:  Over  39  months,  427  nodules  with  a  diagnosis  of  ﬁbroadenoma  were
sampled in  372  patients  using  ultrasound-guided  FNAB.  The  sonographic  appearance  of  all  the
nodules suggested  BI-RADS  category  3  ﬁbroadenomas.  The  mean  size  of  the  ﬁbroadenomas  was
9 mm.  The  mean  duration  of  follow-up  was  29.7  months.
Results:  Seven  nodules  had  atypical  cytology:  a  microbiopsy  and/or  excision  found  a  simple
ﬁbroadenoma  (n  =  3),  mastitis  (n  =  1),  a  ﬁbroadenoma  associated  with  a  papilloma  (n  =  1),  ﬁbro-
sis (n  =  1)  and  normal  tissue  (n  =  1).  Seven  other  nodules  were  resected  during  treatment  for
synchronous  cancer,  and  were  diagnosed  as  ﬁbroadenomas.  Two  hundred  and  seventy-six  nod-
ules were  followed-up  (121  patients  were  lost  to  follow-up  [n  =  132])  and  the  appearance  of  263
nodules (95.29%)  was  stable.  Seven  nodules,  which  had  increased  in  size,  underwent  another
FNAB or  microbiopsy  or  surgery.  Five  nodules  were  not  found  again.  The  borders  of  one  nodule
showed modiﬁcations.
Conclusion:  The  use  of  ﬁne  needle  aspiration  biopsy,  interpreted  by  an  experienced  cytologist,
means that  short  term  follow-up  of  ﬁbroadenomas  can  be  avoided.
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A  ﬁbroadenoma  is  a  frequent,  benign,  ﬁbroepithelial
tumour,  representing  20%  of  all  breast  masses  in  pre-
menopausal  women  and  10%  in  women  after  the  menopause
[1],  with  incidence  peaking  during  the  2nd  and  3rd  decades.
It  usually  presents  as  a  palpable,  ﬁrm,  painless,  mobile  mass.
It  usually  occurs  in  isolation,  but  in  15%  of  cases  there  may
be  several  [2].  Its  size  generally  varies  from  0.5  to  5  cm  for
the  adult  type  and  may  exceed  15  cm  in  the  case  of  juvenile
and  giant  ﬁbroadenomas.  A  slight  increase  in  size  may  occur
during  follow-up,  but  this  must  remain  less  or  equal  to  20%
over  6  months  [3].
The  evolution  of  ﬁbroadenomas  is  affected  by  hormonal
levels  and  they  usually  involute  after  the  menopause.  Simple
adult  ﬁbroadenomas  are  generally  found  in  young  women,
and  contain  stromal  and  epithelial  components  in  varying
proportions.  Cytological  examination  reveals  the  association
of  bare  nuclei,  corresponding  to  the  stroma,  and  map-
like  epithelial  plaques  with  myoepithelial  cells.  There  are
two  special  cases:  sclerotic  ﬁbroadenomas  and  complex
ﬁbroadenomas.  The  best  imaging  technique  for  detecting
and  characterising  ﬁbroadenomas  is  ultrasonography.
Mammography  is  indeed  not  very  speciﬁc  except  for
sclerotic  ﬁbroadenomas  with  ‘popcorn’  calciﬁcations.  With
ultrasound,  a  simple  ﬁbroadenoma  appears  as  a  circum-
scribed  hypo-  or  isoechoic,  homogeneous  mass  with  a  long
axis  parallel  to  the  skin.  It  may  contain  hyperechoic  linear
internal  septa.  Adjacent  breast  tissue  may  be  compressed
and  form  a  hyperechoic  pseudocapsule.  There  is  variable
posterior  acoustic  enhancement  (Fig.  1).
Most  simple  ﬁbroadenomas  are  classiﬁed  as  BI-RADS  3
and  are  closely  monitored,  even  if  they  are  palpable  [4].
Some  are  surgically  removed  depending  on  the  patient’s
risk  factors,  their  size  (>  3  cm)  and  the  patient’s  wishes.
This  close  ultrasound  monitoring  is  a  source  of  worry  for
the  patients.  It  also  poses  the  problem  of  compliance.
Ultrasound-guided  ﬁne  needle  aspiration  biopsy  is  a  simple,
rapid  procedure  with  little  discomfort,  performed  directly
during  the  consultation.  With  an  experienced  cytologist  the
results  are  available  within  24  hours  or  even  within  minutes
if  there  is  a  cytologist  immediately  available.  It  also  means
that  biopsies  and  the  resulting  stress  can  be  avoided.  The
objective  of  this  study  was  to  verify  whether  an  ultrasound-
guided  FNAB  can  avoid  the  need  for  short  term  ultrasound
Figure 1. Simple ﬁbroadenoma: hypoechoic, homogeneous, oval
nodule, parallel to the skin, with a pseudocapsule and septa.
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ollow-up  in  patients  with  a  simple  ﬁbroadenoma  suspected
sing  ultrasound.
atients and methods
his  retrospective  study  was  performed  based  on  histo-
ogical  data  consisting  of  a  list  of  cytological  results  of
broadenomas  over  39  months.  The  study  included  427  nod-
les  in  372  patients  (median:  41  years  old,  extremes:  15  to
6  years  old)  seen  in  our  breast  clinic.  The  patients  con-
ulted  either  in  the  context  of  a  screening  programme  or
f  monitoring  after  treated  breast  cancer  or  after  having
hemselves  felt  a  breast  nodule.  After  recording  their  history
nd  a  clinical  examination,  all  patients  underwent  breast
ltrasound.  In  the  clinical  examination,  where  there  was  a
alpable  nodule,  it  was  considered  benign  if  it  was  mobile,
egular  and  soft.  Certain  patients  (on  average  over  40  years
f  age)  also  had  a  mammogram.  All  the  patients  had  one
r  more  breast  nodules  visualised  by  ultrasound.  FNAB  was
erformed  on  single  nodules.  Where  there  were  several  nod-
les,  only  those  that  had  newly  appeared,  were  large  in  size,
ad  increased  in  size  (>  20%  within  6  months)  or  which  had
riteria  favouring  malignancy  were  subjected  to  FNAB.  Only
odules  given  a  BI-RADS  3  classiﬁcation  were  included  in  the
tudy.  In  all,  FNAB  was  performed  on  427  nodules  of  benign
ppearance.
The  ultrasound  examinations  were  performed  by  radiolo-
ists  with  more  than  10  years’  experience  of  breast  imaging
IL,  LF,  MS)  and  by  assistants  in  training,  on  a  Philips  iU22
ltrasound  system  (Philips  Ultrasound,  Bothell,  WA,  USA)
sing  a 17-5  MHz  linear  probe,  or  possibly  a  12—5  MHz  linear
robe  where  the  lesion  was  deep  and/or  the  breasts  volu-
inous.  All  the  examinations  were  performed  with  direct
isualisation  (PACS)  of  previous  ultrasound  images  when  they
ere  available.  Compound  imaging,  allowing  deﬁnition  of
he  borders  and  the  internal  echostructure  to  be  increased,
as  applied  by  default.  The  nodules  were  considered  to
e  benign  if  they  had  the  following  ultrasound  character-
stics:
oval  in  shape  with  the  long  axis  parallel  to  the  skin;
homogeneous  hypo-  or  isoechoic  parenchyma;
thin  echoic  ‘pseudocapsule’;
the borders  were  regular  in  appearance  with  at  most  little
marked  bi-  or  trilobulation;
±  septa.
The  nodules  were  classiﬁed  according  to  the  ultrasonic
riteria  of  the  BI-RADS  lexicon.
Simple  or  complex  cysts  were  not  included  in  the  study,
or  were  suspect  nodules.
If  the  nodule  was  located  in  a  fatty  environment,  har-
onic  imaging  was  systematically  used  to  increase  contrast.
oppler  was  systematically  applied.  The  location,  the  num-
er  and  the  size  of  the  nodules  in  the  three  axes  were  noted.
fter  ultrasound  location  of  the  nodule,  the  FNAB  was  per-
ormed  using  a  22G  ﬁne  needle  ﬁtted  to  a  10  mL  syringe,  in
urn  ﬁxed  to  a  metal  syringe  pistol  (Cameco® Medical  Ltd.,
ondon),  allowing  aspiration.  Cytological  analysis  looked  for
are  nuclei  (corresponding  to  stromal  cells)  and  map-like
pithelial  plaques  with  myoepithelial  cells,  the  latter  indi-
ating  that  the  lesion  was  benign  [5,6]. The  abundance  of
752  
Table  1  Evolution  of  the  nodules.
Nodules  (total:  427)  n  (%)
Nodules  not  monitored 132  (30.9)
Nodules  subject  to  monitoring  or
an  invasive  procedure
295 (69.09)
Nodules  monitored  at  ±  long-term  276  (64.64)
Stability  of  size 263 (95.29)
Disappearance 5 (1.81)
Increase  in  size 7 (2.54)
Fibroadenoma 4 (1.45)
Area  of  ﬁbrocystic  disease  1  (0.36)
Stable  at  further  ultrasound
monitoring
2 (0.72)
Modiﬁcation  of  borders  (grade  II
lobular  carcinoma)
1  (0.36)
Atypias  7  (2.37)
Fibroadenoma  3  (1.02)
Fibroadenoma  +  papilloma  1  (0.34)
Mastitis  1  (0.34)
Fibrosis  1  (0.34)
Normal  tissue  1  (0.34)
Immediate  resection  19  (6.44)
Ipsilateral  synchronous  neoplasia  7  (2.37)
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pPatient’s  wishes  12  (4.07)
he  material  was  assessed  by  the  cellularity  ‘‘+’’  score  and
raded  as  ‘‘0,  ±,  +++  and  +++’’.
esults
he  results  are  summarised  in  Tables  1  and  2.  Fine  nee-
le  aspiration  was  performed  on  a  total  of  427  nodules  and
roduced  a  cytological  diagnosis  of  ﬁbroadenoma  (with  at
east  one  ‘‘+’’  for  cellularity)  in  372  patients  aged  15  to
6  years  old  (median:  41  years  old).  A  diagnosis  of  simple
broadenoma  had  been  suggested  from  the  ultrasound  for
ll  the  nodules.  The  aspirated  nodules  had  a  large  axis  of
 to  43  mm,  i.e.  a  mean  length  of  9  mm  (SD:  6.7).  Multiple
odules  were  present  in  84  patients  (22.58%).  The  length  of
atient  follow-up  varied  from  6  to  60  months,  with  a  mean
f  29.7  months  (SD:  13.8).  Follow-up  was  possible  for  276
odules  (64.64%),  with  evolution  as  follows:
stable  size  for  263  of  these  nodules  (95.29%);
disappearance  of  ﬁve  nodules  (1.81%),  which  initially
measured  between  5  and  13  mm;
increase  in  size  of  seven  nodules  (>  20%  in  each  of  the
three  axes)  (2.54%);
Table  2  Monitoring  of  the  patients.
Patients  (total:  372)  n  (%)
Regularly  monitored  patients  228  (61.29)
Patients  with  a  problem  of  compliance  144  (38.71)
Monitored  only  at  6  months  18  (4.84)
Did  not  appear  at  6  months  but
returned  later
5 (1.34)
Lost  to  follow-up  121  (32.53)
D
M
d
u
a
o
w
6
r
s
i
tI.  Leconte  et  al.
modiﬁcation  of  the  margins  (irregular)  for  one  nodule
(0.36%).
Of  the  nodules  where  the  size  increased:
three  underwent  repeat  FNAB,  with  a  cytological  diagno-
sis  of  ﬁbroadenoma  (n  =  2)  and  ﬁbrocystic  disease  (n  =  1);
two  were  monitored  using  ultrasound  and  remained  sta-
ble;
one  underwent  surgery  directly,  with  a histological  diag-
nosis  of  ﬁbroadenoma;
one  had  a  microbiopsy  with  resection,  with  a  histological
diagnosis  of  ﬁbroadenoma.
Microbiopsy  was  performed  on  one  nodule  with  modiﬁed
argins,  and  it  was  resected,  with  a  histological  diagnosis  of
rade  II  invasive  lobular  carcinoma  (Fig.  2).  Seven  nodules
ad  atypical  cytology  (2.37%)  and  were  therefore  subjected
o  ultrasound-guided  microbiopsy,  in  some  cases  followed  by
urgical  resection  (n  =  2),  with  a  histological  diagnosis  of:
ﬁbroadenoma:  (n  =  3),  1  of  which  was  resected;
ﬁbroadenoma  and  papilloma  (n  =  1),  with  resection;
mastitis  (n  =  1);
ﬁbrosis  (n  =  1);
normal  tissue  (n  =  1).
Nineteen  nodules  (6.44%)  underwent  surgical  resection
irectly  and  seven  (2.37%)  were  operated  because  of  the
ynchronous  development  of  an  ipsilateral  neoplastic  lesion,
ith  ﬁbroadenoma  diagnosed  from  the  histology.  Twelve
odules  (4.07%)  were  treated  surgically  at  the  patients’
equest.  In  this  case,  they  were  mainly  voluminous  lesions
easuring  from  3  to  43  mm  (median:  29  mm)  in  young
atients  from  15  to  54  years  old  (median:  22  years  old).  In
ne  of  these  patients  aged  17,  histological  examination  of
 31  mm  nodule  produced  a  diagnosis  of  a benign  phyllodes
umour  (Fig.  3).  During  monitoring,  121  patients  (32.53%)
ere  lost  to  follow-up  after  the  ﬁrst  examination,  account-
ng  for  132  nodules  (30.91%).  The  mean  age  of  these  patients
as  37.8  years,  with  extremes  of  15  and  86  years.  Five
atients  (1.34%)  did  not  come  for  the  ultrasound  check-up
t  6  months,  but  returned  after  12  or  24  months.  They  were
atients  aged  between  38  and  45  years  old  (median:  42).
ighteen  patients  (4.84%)  came  solely  to  the  ﬁrst  ultrasound
heck-up  at  6  months  (median  age  of  34.6,  with  extremes  of
8  and  61  years).
One  hundred  and  forty-four  patients  in  all  (38.71%)  had
roblems,  therefore,  with  compliance.
iscussion
ammary  ultrasonography  is  the  standard  examination  for
iagnosis  and  monitoring  of  ﬁbroadenomas.  The  growing
se  of  ultrasonography  for  screening  and  identifying  breast
bnormalities  has  resulted  in  an  increase  in  the  detection
f  benign  nodules.  These  nodules,  classiﬁed  as  BI-RADS  3,
ould  normally  be  subject  to  short  term  follow-up  every
 months  for  2  years.  In  certain  cases,  where  there  are
isk  factors,  the  patient  or  the  clinician  wishes  it,  or  the
ize  is  more  than  3  cm,  biopsy  or  resection  is  performed
mmediately.  Both  of  these  approaches,  biopsy  and  short
erm  follow-up,  cause  stress  for  the  patients  (which  is
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Figure 2. Nodule with angular borders: grade II invasive lobular carc
6 months later.
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phase,  cyclic  pill)  and  pregnancy  (hyperplastic  ﬁbroadeno-Figure 3. Oval, hypoechoic nodule, parallel to the skin with a
septum and a pseudocapsule: benign phyllodes tumour.
nevertheless  greater  for  a  biopsy  than  for  follow-up)  [7—9],
and  a  problem  with  compliance.
In  our  establishment,  with  the  agreement  of  the  gynae-
cologists  and  general  practitioners,  a  ﬁne  needle  aspiration
biopsy  is  performed  during  a  breast  examination.  Unlike
biopsy,  this  procedure  is  quick  to  perform  and  minimally
invasive,  with  very  rapid  results  (<  24  h),  and  is  reliable  with
sensitivity  of  97.1%  and  speciﬁcity  of  99.1%  for  nonpalpa-
ble  lesions  [10]. The  aim  of  this  study  was  thus  to  reduce
patients’  stress,  by  ‘replacing’  biopsy  by  a  less  invasive  pro-
cedure  and  eliminating  short-term  monitoring.
Our  results  show  that  in  the  vast  majority  of  cases
(95.29%)  simple  ﬁbroadenomas  are  stable  at  follow-up  of
more  than  2  years  (a  mean  of  29.7  months).  This  is  in  line
with  the  literature,  which  reports  a  level  of  stable  lesions
at  24  months  of  between  97%  and  99%  [11,12].  Graf  et  al.
showed  stability  at  39  months  for  99.3%  of  the  lesions  [13].
Five  nodules  (1.81%)  were  not  found  again.  Several  expla-
nations  can  be  suggested:  difﬁculty  of  visualisation  in  a  fatty
m
ﬁinoma: a: sagittal plane; b: transverse plane; c: transverse plane
nvironment  (n  =  2)  hence  the  usefulness  of  harmonic  imag-
ng  (Fig.  4a,  b),  menopause  without  hormone  substitution
herapy  (n  =  2),  previous  ultrasound  images  not  available
n  =  1).  There  was  an  increase  in  size  more  than  20%  in  each
f  the  three  axes  in  seven  nodules  (2.54%),  in  line  with  the
iterature  [12]. The  size  of  ﬁbroadenomas  varies  depend-
ng  on  the  hormonal  level  (increasing  in  the  luteal  phase,
uring  pregnancy  and  breast-feeding  and  involuting  at  the
enopause).  An  increase  less  or  equal  to  20%  in  the  mean
iameter  in  6  months  is  tolerated  [3].  Of  these  seven  nod-
les,  two  were  followed-up  and  remained  stable  afterwards.
f  the  nodules  that  were  subjected  to  another  FNAB,  to
iopsy  or  surgery,  there  were  four  ﬁbroadenomas  and  one
ase  of  ﬁbrocystic  disease.  Fibrocystic  disease  nodules  cor-
espond  to  an  intermediate  stage  in  the  formation  of  cysts.
uctal  spaces  are  sometimes  completely  ﬁlled  with  debris
nd  macrophages  and  in  this  case,  the  nodule  appeared  to  be
olid.  It  could  be  confused  with  a  ﬁbroadenoma  at  ultrasound
Fig.  5).
Modiﬁcation  of  the  margins  was  observed  in  1  nodule
hat  was  a  9  mm  invasive  lobular  carcinoma.  Re-reading
he  images  showed  that  the  border  was  already  angular  in
he  previous  examination  (Fig.  2).  This  nodule  was  there-
ore  wrongly  classiﬁed  as  BI-RADS  3  and  should  have  been
lassed  as  BI-RADS  4.  On  cytological  examination,  seven
odules  (2.37%)  showed  cytonuclear  atypia.  Deﬁnitive  his-
ology  (following  microbiopsy  or  surgery)  concluded  that
our  were  ﬁbroadenomas,  including  one  with  a  papilloma,
ne  indicated  mastitis,  one  ﬁbrosis  and  one  normal  tissue.
ytological  atypia  are  sometimes  seen  in  ﬁbroadenomas
ut  are  not  found  in  the  histology.  These  cellular  modi-
cations  are  related  to  the  hormonal  cycle  (proliferationas)  [5,6].
As  for  the  three  other  histological  diagnoses  (mastitis,
brosis  and  normal  tissue),  the  most  likely  explanation  is
754  I.  Leconte  et  al.
Figure 4. Nodule difﬁcult to individualise in a fatty environment: a
enhancement.
Figure 5. Filled area of ﬁbrocystic disease (ductal spaces ﬁlled
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Our  study  has  several  limitations.
First  of  all,  this  was  a  retrospective  study  with  selec-ith debris and macrophages).
oor  targeting  during  microbiopsy.  Twelve  patients  (4.07%)
ished  to  undergo  surgery  directly.  They  were  mainly  young
omen  (<  25  years)  with  palpable  ﬁbroadenomas,  causing
iscomfort  and  sometimes  pain.  One  54-year-old  anx-
ous  patient  with  a  3  mm  ﬁbroadenoma  preferred  surgery.
ibroadenomas  are  surgically  resected  if  they  are  too  volu-
inous,  usually  more  than  3  cm,  or  if  they  are  synchronous
ith  and  close  to  a  neoplastic  lesion.  They  can  be  completely
esected  by  a  vacuum  aspiration  system  if  they  measure  less
han  3  cm  [14]. Cryoablation  treatments  are  also  being  stud-
ed,  with  good  results  for  lesions  of  less  than  2  cm,  but  we
ave  no  long-term  data  available  [15].
One  (0.34%)  31  mm  benign  phyllodes  tumour  was  diag-
osed  among  the  nodules  treated  surgically  in  these
oung  patients.  The  major  problem  with  ﬁbroadenomas
s  differential  diagnosis  with  phyllodes  tumours  on  clini-
al  examination,  and  in  imaging  and  histology.  Phyllodes
umours  are  found  in  middle-aged  women  (median  of
5—49  years  old);  their  mean  size  is  4—5  cm.  One  of  their
haracteristics  is  rapid  growth  in  a  few  weeks,  which  facil-
tates  clinical  monitoring.  The  determining  points  from
ltrasound  in  favour  of  a  phyllodes  tumour  are  considerable
ize  and  the  presence  of  cystic  spaces,  lobulated  borders
nd  a  heterogeneous  parenchyma  [16].
A  total  of  two  false  negatives  from  the  ﬁne  needle  aspi-
ation  biopsy  (0.47%)  were  seen,  in  line  with  the  literature
17],  one  of  which  was  a  benign  phyllodes  tumour.  On  re-
eading,  these  two  nodules  did  not  strictly  adhere  to  the
riteria  for  simple  ﬁbroadenomas  that  could  beneﬁt  from
hort  term  follow-up,  since  one  was  more  than  3  cm  and  the
ther  had  irregular  borders.
t
I: without harmonic imaging; b: with harmonic imaging: contrast
In addition,  the  results  of  this  study  show  a  problem  with
ompliance.  Indeed,  32.53%  of  the  patients  were  lost  to
ollow-up.  These  were  mainly  patients  under  40  years  old,
he  age  advised  in  our  establishment  for  ﬁrst  screening.  Sim-
lar  results,  with  64%  compliance,  have  been  described  in  the
iterature  [18]. Five  patients  between  38  and  45  years  old
id  not  attend  the  6  months  control  but  returned  at  12  or
4  months.  Eighteen  patients,  also  mostly  less  than  40  years
ld,  attended  only  the  control  at  6  months.  This  inadequate
evel  of  compliance  is  an  additional  argument  for  performing
n  FNAB  at  the  outset.  A  reliable  cytological  result  reassures
he  patient  and  the  clinician,  particularly  if  patients  do  not
ome  to  the  check-ups  offered.  Young  patients  of  less  than
5  years  of  age  can  however  be  considered  separately.  In
he  absence  of  risk  factors,  the  risk  of  cancer  is  0.03%  [19].
axwell  et  al.  reported  that  if  there  is  a  palpable  nodule
n  patients  less  than  25  years  old,  a  FNAB  is  not  necessary
f  the  precise  clinical  and  ultrasound  criteria  are  present
o  assert  its  benign  nature.  Clinical  monitoring  may  be  pro-
osed  while  informing  patients  of  the  possible  variation  in
ize  of  the  ﬁbroadenoma  and  of  the  need  to  consult  if  there
s  a non-reversible  increase  in  size.
Another  special  situation  to  mention  concerning  this
opulation  of  young  women  is  pregnancy  (and  breast-
eeding).  During  pregnancy,  the  echogenicity  of  the  breast
arenchyma  decreases  and  the  contrast  between  possi-
le  ﬁbroadenomas  and  the  surrounding  mammary  tissue
ecomes  very  weak.  In  addition,  the  size  of  a  ﬁbroadenoma
nown  before  pregnancy  may  be  modiﬁed,  with  dilatation  of
ntratumoral  ducts  [20]. In  the  absence  of  malignancy  crite-
ia,  such  as  irregular  margins,  a  control  can  be  performed
fter  breast-feeding  has  ﬁnished  (Fig.  6).  It  is  nevertheless
est  to  be  extremely  cautious,  since  cancers  discovered  dur-
ng  pregnancy  are  usually  high  grade  because  they  are  in
oung  women,  with  in  addition  an  inherent  delay  in  diagnosis
ue  to  the  pregnancy  [21,22].  To  conclude,  the  case  should
e  discussed  of  women  at  high  risk  of  breast  cancer.  These
re  notably  women  with  BRCA1  and  2  mutations.  Hamilton
t  al.  have  reported  the  pseudobenign  appearance  of  can-
ers  in  the  BRCA1  population  [23]. However,  these  authors
id  not  take  into  account  the  strict  ultrasound  criteria  for
 benign  nature,  since  the  cancers  considered  as  benign  in
heir  study  were  round  rather  than  oval  in  shape  [24]. Cau-
ion  remains  the  watchword  in  these  at-risk  populations,
hich  include  women  who  have  already  undergone  surgery
or  breast  cancer.ion  bias,  risk  factors  not  having  been  taken  into  account.
n  addition,  patients  coming  for  screening  (>  40  years  of  age
Fibroadenoma:  Can  ﬁne  needle  aspiration  biopsy  avoid  short  term  follow-up?  755
Figure 6. Fibroadenoma: a: before breast-feeding; b: during breast-fe
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the  patient  and  overcomes  non-compliance,  common  inFigure 7. Guidelines for ﬁbroadenomas in women with no high
risk factors for breast cancer.
in  our  establishment)  were  not  separated  from  the  others
(young  patients,  those  coming  for  breast  cancer  monitor-
ing,  those  having  found  a  nodule  by  self-palpation).  Patient
follow-up  time  was  sometimes  insufﬁcient  (6  months  for
18  patients  [4.84%]).  Ultrasound  examinations  were  under-
taken  by  radiologists  with  differing  experience  (seniors
and  juniors),  which  might  have  resulted  in  different  inter-
pretation  of  the  images.  The  6-month  controls  were  not
always  performed  by  the  same  radiologist.  Ultrasonography
is  an  operator-dependent  examination  and  requires  speciﬁc
training  and  high-performance  equipment.  Introduction  of
the  BI-RADS  lexicon  has  however  standardised  interpreta-
w
g
aeding; c: after breast-feeding.
ion  and  action  to  be  taken,  and  the  intra-  and  interobserver
orrelation  for  BI-RADS  classiﬁcation  is  excellent  [25]. In  the
ame  way,  ﬁne  needle  aspiration  biopsy  requires  a  learning
urve.  To  improve  ultrasound  performance,  recent  tech-
ological  developments  such  as  elastography  have  been
eveloped.  Elastography  is  particularly  useful  for  lesions
lassed  in  the  BI-RADS  3  and  BI-RADS  4  categories.  Its  use
ften  means  that  lesions  can  be  reclassiﬁed,  usually  into
I-RADS  2,  and  unnecessary  biopsies  and  close  monitoring
voided  [26—29]. Fleury  et  al.  in  particular  reported  good
orrelation  between  the  elastographic  score  and  the  his-
ology  of  ﬁbroadenomas,  resulting  in  reﬁning  the  diagnosis
30].
Given  the  results  of  this  study,  a  guideline  for  ﬁbroadeno-
as  can  be  proposed  in  women  who  have  no  high  risk  factors
or  breast  cancer  (Fig.  7).
onclusion
t  seems  reasonable  to  propose  routine  surveillance  and
ot  short  term  follow-up  if  cytological  results  indicate
broadenoma,  given  the  high  level  of  stability  over  time
f  ﬁbroadenomas  and  the  very  low  level  of  false  negatives
eported  in  this  study.  Of  course,  this  is  only  true  when  the
ltrasound  criteria  used  are  the  criteria  for  a  ﬁbroadenoma.
 reliable  cytological  result  also  reassures  the  clinician  andomen  under  the  age  of  40.  The  management  model  sug-
ested  is  obviously  only  possible  with  the  cooperation  of
 specialist  breast  cytopathologist.  Nevertheless,  caution
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s  required  in  women  with  a  high  risk  of  breast  cancer,
articularly  women  with  a  BRCA1  and  2  mutations  and
omen  who  have  had  surgery  for  breast  cancer,  in  whom
 biopsy  is  recommended.
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